Group 1 - The stock price of Aier Eye Hospital closed at 13.22 yuan on August 18, 2025, with a 1.30% increase from the previous trading day. The trading volume reached 1.394 million hands, and the turnover was 1.843 billion yuan, with a fluctuation of 2.30% [1] - Aier Eye Hospital operates in the medical services sector, focusing on ophthalmic medical services, including myopia correction, cataract surgery, and retinal disease treatment. The company is expanding its medical service network through domestic and international market layouts [1] - The company has indicated that the prevalence of presbyopia treatment in China is relatively low, but its European subsidiary has extensive experience in this area and is performing well. To meet the aging population's needs, the company has opened presbyopia clinics in multiple hospitals and plans to establish a presbyopia study group to promote related diagnostic and treatment services [1] Group 2 - On August 18, the net inflow of main funds was 47.8489 million yuan, while the net outflow over the past five days amounted to 304 million yuan [2]

Core Viewpoint - As of May 8, 2025, the stock price of Puri Eye Hospital (301239) closed at 43.0 yuan, reflecting a decrease of 1.17% with a turnover rate of 2.33% and a trading volume of 16,500 shares, amounting to a transaction value of 71.48 million yuan [1]. Group 1: Business Operations - Puri Eye Hospital operates as a large-scale non-public ophthalmology specialty medical group, with all its hospitals included in the medical insurance designated point system [2]. - The company has a dual pricing logic for its products and services: it has full pricing autonomy for selective consumer projects and high-end examinations (outside the medical insurance catalog), while it strictly adheres to national medical insurance cost control policies for basic treatments and routine examinations (within the medical insurance catalog) [2]. - The company is leveraging the benefits of medical insurance cost control policies, such as centralized procurement price reductions and optimized payment methods, to enhance the accessibility and affordability of eye disease treatments for patients [2]. Group 2: Financial Flow - On May 8, 2025, the financial flow for Puri Eye Hospital showed a net outflow of 3.06 million yuan from major funds and a net outflow of 2.09 million yuan from speculative funds, while retail investors saw a net inflow of 5.15 million yuan [2].